These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 29791916)

  • 1. Diclofenac Sodium 3% in Hyaluronic Acid 2.5% Gel Significantly Diminishes the Actinic Keratosis Area and Severity Index.
    Schmitz L; Gupta G; Segert MH; Kost R; Sternberg J; Gambichler T; Stockfleth E; Dirschka T
    Skin Pharmacol Physiol; 2018; 31(4):206-211. PubMed ID: 29791916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Photodynamic therapy leads to significant improvement of actinic keratosis area and severity index (AKASI).
    Schmitz L; von Dobbeler C; Gupta G; Gambichler T; Szeimies RM; Morton CA; Dirschka T
    Photodiagnosis Photodyn Ther; 2018 Mar; 21():66-70. PubMed ID: 29051122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A proposed scoring system for assessing the severity of actinic keratosis on the head: actinic keratosis area and severity index.
    Dirschka T; Pellacani G; Micali G; Malvehy J; Stratigos AJ; Casari A; Schmitz L; Gupta G;
    J Eur Acad Dermatol Venereol; 2017 Aug; 31(8):1295-1302. PubMed ID: 28401585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Daylight photodynamic therapy for severe facial and scalp actinic keratosis: a prospective non-sponsored single-centre study employing the actinic keratosis area and severity index (AKASI).
    Jordan M; Ghoreschi K; Eberle FC
    Eur J Dermatol; 2019 Feb; 29(1):67-74. PubMed ID: 30827943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical treatment of actinic keratosis with 3.0% diclofenac in 2.5% hyaluronan gel: review of the literature about the cumulative evidence of its efficacy and safety.
    Javor S; Cozzani E; Parodi A
    G Ital Dermatol Venereol; 2016 Jun; 151(3):275-80. PubMed ID: 26512929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Results of a randomized, placebo-controlled safety and efficacy study of topical diclofenac 3% gel in organ transplant patients with multiple actinic keratoses.
    Ulrich C; Johannsen A; Röwert-Huber J; Ulrich M; Sterry W; Stockfleth E
    Eur J Dermatol; 2010; 20(4):482-8. PubMed ID: 20507841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Actinic keratosis area and severity index (AKASI) is associated with the incidence of squamous cell carcinoma.
    Schmitz L; Gambichler T; Gupta G; Stücker M; Dirschka T
    J Eur Acad Dermatol Venereol; 2018 May; 32(5):752-756. PubMed ID: 29117441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for field cancerisation treatment of actinic keratoses with topical diclofenac in hyaluronic acid.
    Ulrich M; Pellacani G; Ferrandiz C; Lear JT
    Eur J Dermatol; 2014; 24(2):158-67. PubMed ID: 24721544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An open study to assess the efficacy and safety of topical 3% diclofenac in a 2.5% hyaluronic acid gel for the treatment of actinic keratoses.
    Rivers JK; McLean DI
    Arch Dermatol; 1997 Oct; 133(10):1239-42. PubMed ID: 9382562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topical 3.0% diclofenac in 2.5% hyaluronic acid gel induces regression of cancerous transformation in actinic keratoses.
    Dirschka T; Bierhoff E; Pflugfelder A; Garbe C
    J Eur Acad Dermatol Venereol; 2010 Mar; 24(3):258-63. PubMed ID: 19709346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical, dermoscopic and immunohistochemical assessment of actinic keratoses and evaluation of the effectiveness of diclofenac therapy with immunohistochemical analysis.
    Çayirli M; Köse O; Demiriz M
    Arch Dermatol Res; 2013 Jul; 305(5):389-95. PubMed ID: 23397597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PDT with PPIX absorption peaks adjusted wavelengths: Safety and efficacy of a new irradiation procedure for actinic keratoses on the head.
    von Dobbeler C; Schmitz L; Dicke K; Szeimies RM; Dirschka T
    Photodiagnosis Photodyn Ther; 2019 Sep; 27():198-202. PubMed ID: 31176762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase IV, open-label assessment of the treatment of actinic keratosis with 3.0% diclofenac sodium topical gel (Solaraze).
    Nelson C; Rigel D; Smith S; Swanson N; Wolf J
    J Drugs Dermatol; 2004; 3(4):401-7. PubMed ID: 15303784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of topical 3% diclofenac sodium gel and 5% imiquimod cream for the treatment of actinic keratoses.
    Akarsu S; Aktan S; Atahan A; Koç P; Özkan S
    Clin Exp Dermatol; 2011 Jul; 36(5):479-84. PubMed ID: 21418281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Actinic keratosis area and severity index is not correlated with photodynamic therapy procedural pain.
    Sharma A; Vincent L
    Photodiagnosis Photodyn Ther; 2020 Sep; 31():101946. PubMed ID: 32795507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical diclofenac: new preparation. Moderate efficacy in actinic keratosis.
    Prescrire Int; 2004 Aug; 13(72):138-9. PubMed ID: 15532138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic and pharmacodynamic evaluation of ingenol mebutate for the treatment of actinic keratosis.
    Stockfleth E; Bastian M
    Expert Opin Drug Metab Toxicol; 2018 Sep; 14(9):911-918. PubMed ID: 30074409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase IV head-to-head randomized controlled trial comparing ingenol mebutate 0·015% gel with diclofenac sodium 3% gel for the treatment of actinic keratosis on the face or scalp.
    Stockfleth E; Harwood CA; Serra-Guillén C; Larsson T; Østerdal ML; Skov T
    Br J Dermatol; 2018 Feb; 178(2):433-442. PubMed ID: 29030864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-dose 5-fluorouracil in combination with salicylic acid as a new lesion-directed option to treat topically actinic keratoses: histological and clinical study results.
    Stockfleth E; Kerl H; Zwingers T; Willers C
    Br J Dermatol; 2011 Nov; 165(5):1101-8. PubMed ID: 21517801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Open label randomized study comparing 3 months vs. 6 months treatment of actinic keratoses with 3% diclofenac in 2.5% hyaluronic acid gel: a trial of the German Dermatologic Cooperative Oncology Group.
    Pflugfelder A; Welter AK; Leiter U; Weide B; Held L; Eigentler TK; Dirschka T; Stockfleth E; Nashan D; Garbe C;
    J Eur Acad Dermatol Venereol; 2012 Jan; 26(1):48-53. PubMed ID: 21414035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.